Source: Charing Cross vasc symposium April2017
This trial was presented only and not published yet; but the results shown shows more bleeding (1.6% vs 0.3% in control) and more bleeding episodes (4.5% vs 1.7% in control). No fatal consequences noted.
Long term results: 46.7% from interventional arm had post thrombotic syndrome vs 48.2% in control
Both iliofemoral and fenoropopliteal DVTs were included.